Methodist Le Bonheur Healthcare
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1918-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
6
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 2:2
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (40.0%)Phase 4
2 (40.0%)Phase 1
1 (20.0%)Envarsus XL Immunosuppression Following Liver Transplantation
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2021-01-12
- Lead Sponsor
- Methodist Healthcare
- Target Recruit Count
- 110
- Registration Number
- NCT03828058
- Locations
- 🇺🇸
Methodist Healthcare, University Hospital, Memphis, Tennessee, United States
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
Phase 4
Withdrawn
- Conditions
- HypertensionSubarachnoid HemorrhageIntracranial Hemorrhage
- First Posted Date
- 2010-01-05
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Methodist Healthcare
- Registration Number
- NCT01042574
- Locations
- 🇺🇸
Methodist Healthcare, University Hospital, Memphis, Tennessee, United States
Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)
Phase 4
Withdrawn
- Conditions
- Heparin-Induced Thrombocytopenia
- Interventions
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2019-08-13
- Lead Sponsor
- Methodist Healthcare
- Registration Number
- NCT00603824
Brain Tumor Treatment Satisfaction Survey
Completed
- Conditions
- Brain Tumors
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- Methodist Healthcare
- Target Recruit Count
- 105
- Registration Number
- NCT00557375
- Locations
- 🇺🇸
Methodist University Hospital, Memphis, Tennessee, United States
Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
Phase 2
Terminated
- Conditions
- Glioblastoma MultiformeHigh-Grade Glioma
- First Posted Date
- 2007-10-24
- Last Posted Date
- 2009-09-18
- Lead Sponsor
- Methodist Healthcare
- Target Recruit Count
- 40
- Registration Number
- NCT00548938
- Locations
- 🇺🇸
Methodist University Hospital, Memphis, Tennessee, United States
- Prev
- 1
- 2
- Next
News
No news found